Kummar S, Fogarasi M, Canova A, Mota A, Ciesielski T
Department of Medicine, Yale Cancer Center, Yale University School of Medicine and VA Connecticut Cancer Center, VA Connecticut Healthcare System, 950 Campbell Avenue, 111D, West Haven, Connecticut, CT 06516, USA.
Br J Cancer. 2002 Jun 17;86(12):1884-7. doi: 10.1038/sj.bjc.6600326.
The origin of metastatic adenocarcinoma lesions can sometimes be difficult to diagnose. The objectives of our study were to establish the cytokeratin staining pattern of primary and metastatic lung and colorectal adenocarcinomas, and to determine if this helps to identify the site of origin of metastatic lesions. We reviewed a total of 102 tissue samples from patients in our tumour registry, with either primary or metastatic lung or colorectal adenocarcinoma. Tissue sections were stained for cytokeratin 7 and 20 and read as positive or negative for staining. Clinical and radiologic information was reviewed from computerised charts. The cytokeratin 7+/cytokeratin 20- pattern characterised 96% (29 out of 30) of primary and 95% (21 out of 22) of metastatic lung adenocarcinomas. All the primary (26), and 88% (21 out of 24) of metastatic colorectal adenocarcinomas stained cytokeratin 7-/cytokeratin 20+. Samples from a variety of metastatic sites were evaluated for cytokeratin 7 and 20 staining. Out of the 102 samples, in 95% (97 out of 102) of the cases, the cytokeratin 7 and cytokeratin 20 staining pattern characterised and differentiated between lung and colorectal adenocarcinoma. Primary and metastatic lung adenocarcinomas show a cytokeratin 7+/cytokeratin 20- staining pattern, while colorectal adenocarcinomas stain cytokeratin 7-/cytokeratin 20+. Cytokeratin staining is helpful in the diagnostic differentiation of metastatic lesions from these two common primaries, and assists in determining the site of origin of metastatic lesions.
转移性腺癌病灶的起源有时难以诊断。我们研究的目的是确定原发性和转移性肺及结肠直肠腺癌的细胞角蛋白染色模式,并确定这是否有助于识别转移性病灶的起源部位。我们回顾了肿瘤登记处中102例原发性或转移性肺或结肠直肠腺癌患者的组织样本。对组织切片进行细胞角蛋白7和20染色,并判断染色为阳性或阴性。从计算机化图表中回顾临床和放射学信息。细胞角蛋白7阳性/细胞角蛋白20阴性模式在96%(30例中的29例)的原发性肺腺癌和95%(22例中的21例)的转移性肺腺癌中出现。所有原发性结肠直肠癌(26例)以及88%(24例中的21例)的转移性结肠直肠癌细胞角蛋白7阴性/细胞角蛋白20阳性。对来自各种转移部位的样本进行细胞角蛋白7和20染色评估。在102个样本中,95%(102例中的97例)的病例中,细胞角蛋白7和细胞角蛋白20染色模式可对肺腺癌和结肠直肠癌进行特征性区分。原发性和转移性肺腺癌表现为细胞角蛋白7阳性/细胞角蛋白20阴性染色模式,而结肠直肠癌为细胞角蛋白7阴性/细胞角蛋白20阳性染色。细胞角蛋白染色有助于鉴别这两种常见原发肿瘤的转移性病灶,并有助于确定转移性病灶的起源部位。